Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries

CompletedOBSERVATIONAL
Enrollment

203

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

April 28, 2017

Study Completion Date

April 28, 2017

Conditions
Rheumatoid Arthritis
Trial Locations (36)

3203

Hospital Elche, Elche

3600

Hospital Elda, Elda

Local Institution, Elda

6800

Hospital Merida, Mérida

8056

Local Institution, Zwickau

Zwickau, Zwickau

8221

Hospital Mutua de Terrasa, Terrassa

9669

Local Institution, Frankenberg

10600

Hospital Virgen del Puerto, Plasencia

Local Institution, Plasencia

15006

Hospital Coruña, A Coruña

17176

Local Institution, Solna

20502

Local Institution, Malmo

22300

Hospital Ccal. de Barbastro, Barbastro

28007

Hospital Gregorio Marañon, Madrid

Local Institution, Madrid

28905

Hospital Getafe, Getafe

41009

Hospital Virgen Macarena, Seville

55543

Acura Kliniken, Bad Kreuznach

Local Institution, Bad Kreuznach

61231

Bad Nauheim, Bad Nauheim

Local Institution, Bad Nauheim

69120

Local Institution, Heidelberg

Universitätsklinikum Heidelberg, Heidelberg

69121

Heidelberg, Heidelberg

75571

APHM - Hopital Sainte-Marguerite, Marseille, Paris

87042

CHU Limoges - Hopital Dupuytren, Limoges

NP7 7EG

Nevil Hall Hospital, Abergavenny

RG24 9NA

Local Institution, Basingstoke

DE22 3NE

Royal Derby Hospital, Derby

WF13 4HS

Barnsley Hospital NHS Foundation Trust, Dewsbury

BN21 2UD

Eastbourne District Gen. Hosp., East Sussex

CM20 1QX

Local Institution, Harlow

Princess Alexandra Hospital, Harlow

CH49 5PE

Arrow Park Hospital, Metropolitan Borough of Wirral

WA9 3DA

St Helens Hospital, St Helens

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02632890 - Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries | Biotech Hunter | Biotech Hunter